271 – 280 of 324
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Commentary : Magnetic resonance imaging as an evaluative tool in haemophilic arthropathy, on behalf of the medical advisory board, World Federation of Haemophilia and the International Prophylaxis Study Group
- Contribution to journal › Debate/Note/Editorial
- 2004
-
Mark
Willingness to pay for on-demand and prophylactic treatment for severe haemophilia in Sweden.
- Contribution to journal › Article
-
Mark
Untitled - Introduction
- Contribution to journal › Debate/Note/Editorial
-
Mark
Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A
- Contribution to journal › Article
-
Mark
A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia
- Contribution to journal › Article
-
Mark
Optimizing factor prophylaxis for the haemophilia population: where do we stand?
- Contribution to journal › Article
-
Mark
A new magnetic resonance imaging scoring method for assessment of haemophilic arthropathy.
- Contribution to journal › Article
-
Mark
Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden.
- Contribution to journal › Article
-
Mark
Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions
- Contribution to journal › Article
-
Mark
A comparative in vitro evaluation of six von Willebrand factor concentrates.
- Contribution to journal › Article
